Stem cell transplantation: graft-mediated antileukemia effects.

William Hogan, Hans Joachim Deeg

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Graft-mediated antileukemia (GVL) activity is a major factor contributing to the success of allogeneic hematopoietic stem transplantation (aHCT). Recent advances have permitted the establishment of GVL activity without the need for a myeloablative conditioning regimen, thereby permitting even older and sicker patients to avail of potentially curative therapy. Use of adoptive immunotherapy by combining reduced intensity conditioning and donor leukocyte infusion (DLI) has resulted in strategies that can be exploited to maximize GVL effects while minimizing toxicity. These advances, combined with new molecularly targeted agents, creates new possibilities to develop less toxic, curative therapy for a greater number of patients. This review summarizes pertinent information regarding the evidence in favor of GVL effects, the impact of disease type and mechanisms of GVL.

Original languageEnglish (US)
Pages (from-to)421-444
Number of pages24
JournalMethods in molecular medicine
Volume109
StatePublished - 2005
Externally publishedYes

Fingerprint

Stem Cell Transplantation
Transplants
Adoptive Immunotherapy
Poisons
Leukocytes
Transplantation
Tissue Donors
Therapeutics

Cite this

Stem cell transplantation : graft-mediated antileukemia effects. / Hogan, William; Deeg, Hans Joachim.

In: Methods in molecular medicine, Vol. 109, 2005, p. 421-444.

Research output: Contribution to journalReview article

@article{865c1165bc0a4e69aa96136f93bba469,
title = "Stem cell transplantation: graft-mediated antileukemia effects.",
abstract = "Graft-mediated antileukemia (GVL) activity is a major factor contributing to the success of allogeneic hematopoietic stem transplantation (aHCT). Recent advances have permitted the establishment of GVL activity without the need for a myeloablative conditioning regimen, thereby permitting even older and sicker patients to avail of potentially curative therapy. Use of adoptive immunotherapy by combining reduced intensity conditioning and donor leukocyte infusion (DLI) has resulted in strategies that can be exploited to maximize GVL effects while minimizing toxicity. These advances, combined with new molecularly targeted agents, creates new possibilities to develop less toxic, curative therapy for a greater number of patients. This review summarizes pertinent information regarding the evidence in favor of GVL effects, the impact of disease type and mechanisms of GVL.",
author = "William Hogan and Deeg, {Hans Joachim}",
year = "2005",
language = "English (US)",
volume = "109",
pages = "421--444",
journal = "Methods in molecular medicine",
issn = "1543-1894",
publisher = "Humana Press",

}

TY - JOUR

T1 - Stem cell transplantation

T2 - graft-mediated antileukemia effects.

AU - Hogan, William

AU - Deeg, Hans Joachim

PY - 2005

Y1 - 2005

N2 - Graft-mediated antileukemia (GVL) activity is a major factor contributing to the success of allogeneic hematopoietic stem transplantation (aHCT). Recent advances have permitted the establishment of GVL activity without the need for a myeloablative conditioning regimen, thereby permitting even older and sicker patients to avail of potentially curative therapy. Use of adoptive immunotherapy by combining reduced intensity conditioning and donor leukocyte infusion (DLI) has resulted in strategies that can be exploited to maximize GVL effects while minimizing toxicity. These advances, combined with new molecularly targeted agents, creates new possibilities to develop less toxic, curative therapy for a greater number of patients. This review summarizes pertinent information regarding the evidence in favor of GVL effects, the impact of disease type and mechanisms of GVL.

AB - Graft-mediated antileukemia (GVL) activity is a major factor contributing to the success of allogeneic hematopoietic stem transplantation (aHCT). Recent advances have permitted the establishment of GVL activity without the need for a myeloablative conditioning regimen, thereby permitting even older and sicker patients to avail of potentially curative therapy. Use of adoptive immunotherapy by combining reduced intensity conditioning and donor leukocyte infusion (DLI) has resulted in strategies that can be exploited to maximize GVL effects while minimizing toxicity. These advances, combined with new molecularly targeted agents, creates new possibilities to develop less toxic, curative therapy for a greater number of patients. This review summarizes pertinent information regarding the evidence in favor of GVL effects, the impact of disease type and mechanisms of GVL.

UR - http://www.scopus.com/inward/record.url?scp=16644367546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644367546&partnerID=8YFLogxK

M3 - Review article

C2 - 15585936

AN - SCOPUS:16644367546

VL - 109

SP - 421

EP - 444

JO - Methods in molecular medicine

JF - Methods in molecular medicine

SN - 1543-1894

ER -